Best Hospitals for Robotic Hysterectomy in Chennai, India

A hysterectomy — the surgical removal of the uterus — is one of the most commonly performed major gynecologic procedures worldwide, indicated for a spectrum of conditions including uterine fibroids (leiomyomata), endometriosis, adenomyosis, uterine prolapse, abnormal uterine bleeding refractory to medical management, and uterine or cervical malignancies. Physiologically, the uterus lies at the anatomical center of the female pelvis, in close proximity to the bladder anteriorly, the rectum posteriorly, and bilateral ureters and ovarian vasculature laterally; any surgical approach must meticulously account for these structures to prevent iatrogenic injury. Depending on the indication and the patient's reproductive status, the procedure may be total (removal of uterus and cervix), subtotal/supracervical (uterine corpus only), or radical (uterus, cervix, upper vagina, and parametria — typically for malignancy), with or without bilateral salpingo-oophorectomy (BSO).

• MEDICAL INDICATIONS (WHO IS ELIGIBLE):
• Symptomatic uterine fibroids (leiomyomata) causing menorrhagia, bulk symptoms, pelvic pressure, or urinary frequency, unresponsive to GnRH agonist therapy (e.g., leuprolide acetate) or levonorgestrel IUD
• Adenomyosis with debilitating dysmenorrhea and/or heavy menstrual bleeding, confirmed on MRI (junctional zone thickness >12 mm)
• Severe endometriosis (ASRM Stage III–IV) with rectovaginal nodules, hydrosalpinx, or recurrent ovarian endometriomas after medical failure
• Abnormal uterine bleeding (AUB) not controlled by tranexamic acid, combined oral contraceptives, or progestins, with endometrial hyperplasia with or without atypia
• +24 more

APPROACH 1 — TOTAL ROBOTIC HYSTERECTOMY (TRH) WITH DA VINCI XI SYSTEM (MOST COMMON):

The da Vinci Xi platform is the current generation system used in the majority of robotic gynecologic cases globally. The patient is positioned in dorsal lithotomy with steep Trendelenburg (25–30°). A 12 mm umbilical port is placed for the 3D endoscope; three 8 mm robotic instrument ports are placed in the lower abdomen; an additional 5–10 mm assistant port facilitates suction, irrigation, clip application, and specimen retrieval. The uterine manipulator (e.g., RUMI II or Koh Colpotomizer system) delineates the cervicovaginal junction, enabling precise colpotomy. Robotic instruments employed include monopolar curved scissors, bipolar Maryland forceps, vessel sealing devices (e.g., Intuitive's vessel sealer), and needle drivers. The surgical sequence involves: (1) development of vesicouterine space and bladder flap, (2) identification and isolation of bilateral ureters, (3) ligation of uterine vessels at their origin, (4) parametrial dissection, (5) colpotomy along the Koh ring, and (6) uterine removal vaginally with morcellation avoided in all cases of suspected or confirmed malignancy. Vaginal cuff closure is performed robotically using barbed suture (V-Loc or Stratafix 0-PDS) in a running locking fashion — a technically superior closure that reduces cuff dehiscence rates compared to laparoscopic technique.

APPROACH 2 — ROBOTIC RADICAL HYSTERECTOMY (TYPE III, PIVER-RUTLEDGE / QUERLEU-MORROW CLASS C):

For early-stage cervical cancer (FIGO IB1, select IB2) and endometrial carcinoma with cervical involvement, radical hysterectomy includes en-bloc removal of the uterus, cervix, upper 1–2 cm of vagina, cardinal and uterosacral ligaments (parametria), and bilateral pelvic lymph node dissection. The robotic platform is particularly advantageous here due to the need for precise parametrial dissection adjacent to the ureter's 'knee' and the internal iliac vasculature. Sentinel lymph node mapping using ICG (indocyanine green) fluorescence via the da Vinci FireFly imaging system has become standard practice at leading centers, reducing the morbidity of full pelvic lymphadenectomy in early-stage disease.

PHASE 1 — Pre-travel Preparation (4–6 WEEKS Before DEPARTURE):

• Submit medical records to GAF Healthcare's clinical team: operative notes, imaging (TVUS, MRI, PET-CT), biopsy pathology reports, recent blood work, and anesthesia history
• GAF Healthcare's partner gynecologic oncologist or robotic surgeon reviews case within 48–72 hours and issues a formal treatment plan with itemized cost estimate
• Obtain e-Medical Visa (India) or UAE entry visa with GAF Healthcare facilitation (typically processed within 3–5 business days)
• Pre-operative optimization at home: correction of anemia (IV iron infusion or oral iron supplementation), GnRH agonist therapy (leuprolide acetate 3.75 mg IM monthly × 2–3 months) if indicated to shrink fibroids and replenish hemoglobin, cessation of anticoagulants/NSAIDs as instructed
• Bowel preparation instructions and antibiotic prophylaxis protocol provided (e.g., single-dose IV cefazolin 2 g within 60 minutes of incision, or clindamycin if penicillin-allergic, per ACOG guidelines)

PHASE 2 — Arrival AND Pre-operative Workup (2–3 DAYS Before SURGERY):